References
- Aziz, M. A.; Rahma, G. E. D. A. A.; Hassan, A. A. Synthesis of Novel Pyrazole Derivatives and Evaluation of their Antidepressant and Anticonvulsant Activities. Eur. J. Med. Chem. 2009, 44, 3480–3487. DOI: https://doi.org/10.1016/j.ejmech.2009.01.032.
- Vijesh, A. M.; Isloor, A. M.; Shetty, P.; Sundershan, S.; Fun, H. K. New Pyrazole Derivatives Containing 1,2,4-Triazoles and Benzoxazoles as Potent Antimicrobial and Analgesic Agents. Eur. J. Med. Chem. 2013, 62, 410–415. DOI: https://doi.org/10.1016/j.ejmech.2012.12.057.
- Perry, B.; Beevers, R.; Bennett, G.; Buckley, G.; Crabbe, T.; Gowers, L.; James, L.; Jenkins, K.; Lock, C.; Sabin, V.; et al. Optimization of a Series of Multi-Isoform PI3 Kinase Inhibitors. Bioorg. Med. Chem. Lett. 2008, 18, 5299–5302. DOI: https://doi.org/10.1016/j.bmcl.2008.08.042.
- Bekhit, A. A.; Ashour, H. M. A.; Ghany, Y. S. A.; Bekhit, A. E. D. B.; Baraka, A. Synthesis and Biological Evaluation of Some Thiazolyl and Thiadiazolyl Derivatives of 1H-Pyrazole as Anti-Inflammatory Antimicrobial Agents. Eur. J. Med. Chem. 2008, 43, 456–463. DOI: https://doi.org/10.1016/j.ejmech.2007.03.030.
- Chovatia, P. T.; Akabari, J. D.; Kachhadia, P. K.; Zalavadia, P. D.; Joshi, H. S. Synthesis and Selective Antitubercular and Antimicrobial Inhibitory Activity of 1-Acetyl-3,5-Diphenyl-4,5-Dihydro-(1H)-Pyrazole Derivatives. J. Serb. Chem. Soc. 2006, 71, 713–720. DOI: https://doi.org/10.2298/JSC0607713C.
- Mruthyunjayaswamy, B. H. M.; Basavarajaiah, S. M. Synthesis and Antimicrobial Activity of Novel Ethyl-5-(Ethoxycarbonyl)-4-Methylthiazol-2-yl-Carbamate Compounds. Indian J. Chem. 2009, 48, 1274–1278.
- Liu, X.-H.; Cui, P.; Song, B.-A.; Bhadury, P. S.; Zhu, H.-L.; Wang, S.-F. Synthesis, Structure and Antibacterial Activity of Novel 1-(5-Substituted-3-Substituted-4,5-Dihydropyrazol-1-yl)Ethanone Oxime Ester Derivatives. Bioorg. Med. Chem. 2008, 16, 4075–4082. DOI: https://doi.org/10.1016/j.bmc.2008.01.035.
- Liu, X.-H.; Zhu, J.; Zhou, A.-N.; Song, B.-A.; Zhu, H.-L.; Bai, L.-S.; Bhadury, P. S.; Pan, C.-X. Synthesis, Structure and Antibacterial Activity of New 2-(1-(2-(substituted-phenyl)-5-methyloxazol-4-yl)-3-(2-substitued-phenyl)-4,5-dihydro-1H-pyrazol-5-yl)-7-substitued-1,2,3,4-tetrahydroisoquinoline Derivatives. Bioorg. Med. Chem. 2009, 17, 1207–1213. DOI: https://doi.org/10.1016/j.bmc.2008.12.034.
- Liu, X.; Zhu, J.; Pan, C.; Song, B.; Li, B. Synthesis and Fungicidal Activity of Novel 3,5-Diarylpyrazole Derivatives. Front. Chem. China. 2008, 3, 418–421. DOI: https://doi.org/10.1007/s11458-008-0075-3.
- Gholap, S. S. Synthesis and Antibacterial Screening of Some Pyrazole and Chromone Derivatives. Heterocycl. Lett. 2012, 2, 461–466.
- Castagnolo, D.; De Logu, A.; Radi, M.; Bechi, B.; Manetti, F.; Magnani, M.; Supino, S.; Meleddu, R.; Chisu, L.; Botta, M. Synthesis, Biological Evaluation and SAR Study of Novel Pyrazole Analogues as Inhibitors of Mycobacterium tuberculosis. Bioorg. Med. Chem. 2008, 16, 8587–8591. DOI: https://doi.org/10.1016/j.bmc.2008.08.016.
- Shetty, S. C.; Bhagat, V. C. Synthesis and Pharmacological Activities of 3-(4-Substituted Phenyl)-1-Phenyl-1Hpyrazole-4-Carboxaldehyde and its Aldimines Derivatives. Asian J. Chem. 2008, 20, 5037–5045.
- Hashem, A. I.; Youssef, A. S. A.; Kandeel, K. A.; Elmagd, W. S. I. A. Conversion of Some 2(3H)-Furanones Bearing a Pyrazolyl Group into Other Heterocyclic Systems with a Study of their Antiviral Activity. Eur. J. Med. Chem. 2007, 42, 934–939. DOI: https://doi.org/10.1016/j.ejmech.2006.12.032.
- Sabbagh, O. I.; Baraka, M. M.; Ibrahim, S. M.; Pannecouque, C.; Andrei, G.; Snoeck, R.; Balzarini, J.; Rashad, A. A. Synthesis and Antiviral Activity of New Pyrazole and Thiazole Derivatives. Eur. J. Med. Chem. 2009, 44, 3746–3753. DOI: https://doi.org/10.1016/j.ejmech.2009.03.038.
- El-Borai, M. A.; Rizk, H. F.; Sadek, M. R.; El-Keiy, M. M. An Eco-Friendly Synthesis of Heterocyclic Moieties Condensed with Pyrazole System under Green Conditions and Their Biological Activity. GSC. 2016, 06, 88–100. DOI: https://doi.org/10.4236/gsc.2016.62008.
- Jouha, J.; Loubidi, M.; Bouali, J.; Hamri, S.; Hafid, A.; Suzenet, F.; Guillaumet, G.; Dagcı, T.; Khouili, M.; Aydın, F.; et al. Synthesis of New Heterocyclic Compounds Based on Pyrazolopyridine Scaffold and Evaluation of their Neuroprotective Potential in MPP+-Induced Neurodegeneration. Eur. J. Med. Chem. 2017, 129, 41–52. DOI: https://doi.org/10.1016/j.ejmech.2017.02.019.
- Pinto, D. J. P.; Orwat, M. J.; Koch, S.; Rossi, K. A.; Alexander, R. S.; Smallwood, A.; Wong, P. C.; Rendina, A. R.; Luettgen, J. M.; Knabb, R. M.; et al. Discovery of 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxopiperidin-1-yl)Phenyl)-4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-c]Pyridine-3-Carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa. J. Med. Chem. 2007, 50, 5339–5356. DOI: https://doi.org/10.1021/jm070245n.
- Jing, L.; Tang, Y.; Xiao, Z. Discovery of Novel CDK Inhibitors via Scaffold Hopping from CAN508. Bioorg. Med. Chem. Lett. 2018, 28, 1386–1391. DOI: https://doi.org/10.1016/j.bmcl.2018.02.054.
- Elnagdi, M. N.; Elmoghayar, M. R. H.; Elgemeie, G. E. H. Chemistry of Pyrazolopyrimi -Dines. Adv. Heterocyclic Chem. 1987, 41, 319–376. DOI: https://doi.org/10.1016/S0065-2725(08)60164-6.
- Nafie, M. S.; Amer, A. M.; Mohamed, A. K.; Tantawy, E. S. Discovery of Novel Pyrazolo[3,4-b]pyridine Scaffold-Based Derivatives As Potential PIM-1 Kinase Inhibitors In Breast Cancer MCF-7 Cells. Bioorg. Med. Chem. 2020, 28, 115828. DOI: https://doi.org/10.1016/j.bmc.2020.115828.
- Eagon, S.; Hammill, J. T.; Sigal, M.; Ahn, K. J.; Tryhorn, J. E.; Koch, G.; Belanger, B.; Chaplan, C. A.; Loop, L.; Kashtanova, A. S.; et al. Synthesis and Structure-Activity Relationship of Dual-Stage Antimalarial Pyrazolo[3,4-b]pyridines. J. Med. Chem. 2020, 63, 11902–11919. DOI: https://doi.org/10.1021/acs.jmedchem.0c01152.
- Pfaffenrot, B.; Kl€Ovekorn, P.; Juchum, M.; Selig, R.; Albrecht, W.; Zender, L.; Laufer, S. A. Design and Synthesis of 1H-Pyrazolo[3,4-b]Pyridines Targeting Mitogen-Activated Protein Kinase Kinase 4 (MKK4) – A Promising Target for Liver Regeneration. Eur. J. Med. Chem. 2021, 218, 113371. DOI: https://doi.org/10.1016/j.ejmech.2021.113371.
- Gudmundsson, K. S.; Johns, B. A.; Wang, Z.; Turner, E. M.; Allen, S. H.; Freeman, G. A.; Boyd, F. L.; Sexton, C. J.; Selleseth, D. W.; Moniri, K. R.; et al. Synthesis of Novel Substituted 2-Phenylpyrazolopyridines with Potent Activity Against Herpesviruses. Bioorg. Med. Chem. 2005, 13, 5346–5361. DOI: https://doi.org/10.1016/j.bmc.2005.05.043.
- Abdel-Monem, Y. K.; El-Enein, S. A. A.; El-Sheikh-Amer, M. M. Design of New Metal Complexes of 2-(3-Amino-4,6-Dimethyl-1H-Pyrazolo[3,4-b]Pyridin-1-yl)Aceto-Hydrazide: Synthesis, Characterization, Modelling and Antioxidant Activity. J. Mol. Struct. 2017, 1127, 386–396. DOI: https://doi.org/10.1016/j.molstruc.2016.07.110.
- El-Gohary, N. S.; Gabr, M. T.; Shaaban, M. I. Synthesis, Molecular Modeling and Biological Evaluation of New Pyrazolo[3,4-b]Pyridine Analogs as Potential Antimicrobial, Antiquorum-Sensing and Anticancer Agents. Bioorg. Chem. 2019, 89, 102976. DOI: https://doi.org/10.1016/j.bioorg.2019.102976.
- Lee, S.; Park, S. B. An Efficient One-Step Synthesis of Heterobiaryl Pyrazolo[3,4-b]pyridines via Indole Ring Opening . Org. Lett. 2009, 11, 5214–5217. DOI: https://doi.org/10.1021/ol902147u.
- Wenglowsky, S. Pyrazolo[3,4-b]pyridine Kinase Inhibitors: A Patent Review (2008-Present) ). Expert Opin. Ther. Pat. 2013, 23, 281–298. DOI: https://doi.org/10.1517/13543776.2013.749861.
- Nam, Y.; Hwang, D.; Kim, N.; Seo, H. S.; Selim, K. B.; Sim, T. Identification of 1H-Pyrazolo[3,4-b]Pyridine Derivatives as Potent ALKL1196M Inhibitors. J. Enzyme Inhib. Med. Chem. 2019, 34, 1426–1438. DOI: https://doi.org/10.1080/14756366.2019.1639694.
- Huang, S.; Lin, R.; Yu, Y.; Lu, Y.; Connolly, P. J.; Chiu, G.; Li, S.; Emanuel, S. L.; Middleton, S. A. Synthesis of 3-(1H-Benzimidazol-2-yl)-5-Isoquinolin-4-Ylpyrazolo[1,2-b]Pyridine, a Potent Cyclin Dependent Kinase 1 (CDK1) Inhibitor. Bioorg. Med. Chem. Lett. 2007, 17, 1243–1245. DOI: https://doi.org/10.1016/j.bmcl.2006.12.031.
- Hunter, T. Signaling-2000 and Beyond. Cell. 2000, 100, 113–127. DOI: https://doi.org/10.1016/S0092-8674(00)81688-8.
- Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S. The Protein Kinase Complement of the Human Genome. Science. 2002, 298, 1912–1934. DOI: https://doi.org/10.1126/science.1075762.
- Zhao, B.; Li, Y.; Xu, P.; Dai, Y.; Luo, C.; Sun, Y.; Ai, J.; Geng, M.; Duan, W. Discovery of Substituted 1H-Pyrazolo[3,4-b]Pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors. ACS Med. Chem. Lett. 2016, 7, 629–634. DOI: https://doi.org/10.1021/acsmedchemlett.6b00066.
- Chen, C.; Pan, P.; Deng, Z.; Wang, D.; Wu, Q.; Xu, L.; Hou, T.; Cui, S. Discovery of 3,6-Diaryl-1H-Pyrazolo[3,4-b]Pyridines as Potent Anaplastic Lymphoma Kinase (ALK) Inhibitors. Bioorg. Med. Chem. Lett. 2019, 29, 912–916. DOI: https://doi.org/10.1016/j.bmcl.2019.01.037.
- Jian, X.; Yang, F.; Jiang, C. S.; You, W. W.; Zhao, P. L. Synthesis and Biological Evaluation of Novel Pyrazolo[3,4-b]Pyridines as cis-Restricted Combretastatin A-4 Analogues. Bioorg. Med. Chem. Lett. 2020, 30, 127025. DOI: https://doi.org/10.1016/j.bmcl.2020.127025.
- Kitzen, J. J. E. M.; de Jonge, M. J. A.; Verweij, J. Aurora Kinase Inhibitors. Crit. Rev. Oncol. Hematol. 2010, 73, 99–110. DOI: https://doi.org/10.1016/j.critrevonc.2009.03.009.
- Ommer, J.; Selfe, J. L.; Wachtel, M.; O’Brien, E. M.; Laubscher, D.; Roemmele, M.; Kasper, S.; Delattre, O.; Surdez, D.; Petts, G.; et al. Aurora a Kinase Inhibition Destabilizes PAX3-FOXO1 and MYCN and Synergizes with Navitoclax to Induce Rhabdomyosarcoma Cell Death. Cancer Res. 2020, 80, 832–842. DOI: https://doi.org/10.1158/0008-5472.CAN-19-1479.
- Gong, X.; Du, J.; Parsons, S. H.; Merzoug, F. F.; Webster, Y.; Iversen, P. W.; Chio, L. C.; Horn, R. D. V.; Lin, X.; Blosser, W.; et al. Aurora a Kinase Inhibition is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene. Cancer Discov. 2019, 9, 248–263. DOI: https://doi.org/10.1158/2159-8290.CD-18-0469.
- Damodaran, A. P.; Vaufrey, L.; Gavard, O.; Prigent, C. Aurora a Kinase is a Priority Pharmaceutical Target for the Treatment of Cancers. Trends Pharmacol. Sci. 2017, 38, 687–700. DOI: https://doi.org/10.1016/j.tips.2017.05.003.
- Shi, J.; Xu, G.; Zhu, W.; Ye, H.; Yang, S.; Luo, Y.; Han, J.; Yang, J.; Li, R.; Wei, Y.; Chen, L. Design and Synthesis of 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles and Pyrazolo[3,4-b]pyridines for Aurora-A Kinase Inhibitors. Bioorg. Med. Chem. Lett. 2010, 20, 4273–4278. DOI: https://doi.org/10.1016/j.bmcl.2010.04.083.
- Duan, X.; Mu, M.; Yan, J.; Bai, L.; Zhong, L.; Zhu, Y.; Pan, H.; Zhang, M.; Shi, J. Co-Delivery of Aurora-a Inhibitor XY-4 and Bcl-xl siRNA Enhances Antitumor Efficacy for Melanoma Therapy. Int. J. Nanomedicine. 2018, 13, 1443–1456. DOI: https://doi.org/10.2147/IJN.S147759.
- Hill, M. D.; Fang, H.; Brown, J. M.; Molski, T.; Easton, A.; Han, X.; Miller, R.; Hill-Drzewi, M.; Gallagher, L.; Matchett, M.; et al. Development of 1H-Pyrazolo[3,4-b]Pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators. ACS Med. Chem. Lett. 2016, 7, 1082–1086. DOI: https://doi.org/10.1021/acsmedchemlett.6b00292.
- Sumran, G.; Aggarwal, R.; Mittal, A.; Aggarwal, A.; Gupta, A. Design, Synthesis and Photoinduced DNA Cleavage Studies of [1,2,4]-Triazolo[4,3-a]quinoxalin-4(5H)-ones . Bioorg. Chem. 2019, 88, 102932. DOI: https://doi.org/10.1016/j.bioorg.2019.102932.
- Aggarwal, M. R.; Sadana, R.; Ilag, J.; Sumran, G. Synthesis and Bioevaluation of 6-Chloropyridazin-3-yl Hydrazones and 6-Chloro-3-Substituted-[1,2,4]Triazolo[4,3-b]Pyridazines as Cytotoxic Agents. Bioorg. Chem. 2019, 86, 288–295. DOI: https://doi.org/10.1016/j.bioorg.2019.01.049.
- Aggarwal, R.; Kumar, S.; Mittal, A.; Sadana, R.; Dutt, V. Synthesis, Characterization, in Vitro DNA Photocleavage and Cytotoxicity Studies of 4-Arylazo-1-Phenyl-3-(2-Thienyl)-5-Hydroxy-5-Trifluoromethylpyrazolines and Regioisomeric 4-Arylazo-1-Phenyl-5(3)-(2-Thienyl)-3(5)-Trifluoromethylpyrazoles. J. Fluorine Chem. 2020, 236, 109573. DOI: https://doi.org/10.1016/j.jfluchem.2020.109573.
- Aggarwal, R.; Kumar, S. 5-Aminopyrazole as Precursor in Design and Synthesis of Fused Pyrazoloazines. Beilstein J. Org. Chem. 2018, 14, 203–242. DOI: https://doi.org/10.3762/bjoc.14.15.
- Aggarwal, R.; Singh, G.; Kumar, S.; McCabe, T.; Rozas, I. Preparation of 4,7‐Dihydro‐1H ‐Pyrazolo[3,4‐b]Pyridine‐5‐Nitriles in a Multicomponent Domino Process. Chem. Select 2016, 1, 5990– 5994. DOI: https://doi.org/10.1002/slct.201601201.
- Aggarwal, R.; Kumar, S.; Singh, G. Multi-Component Reaction to Access a Library of Polyfunctionally Substituted 4,7-Dihydropyrazolo[3,4-b]Pyridines. Synth. Commun. 2019, 49, 973–985. DOI: https://doi.org/10.1080/00397911.2019.1582064.
- Aggarwal, R.; Sumran, G.; Garg, N.; Aggarwal, A. A Regioselective Synthesis of Some New Pyrazol-1'-ylpyrazolo[1,5-a]pyrimidines in Aqueous Medium and their Evaluation as antimicrobial Agents. Eur. J. Med. Chem. 2011, 46, 3038–3046. DOI: https://doi.org/10.1016/j.ejmech.2011.04.041.
- Aggarwal, R.; Kumar, V.; Bansal, A.; Sanz, D.; Claramunt, R. M. Multi-Component Solvent-Free versus Stepwise Solvent Mediated Reactions: Regiospecific Formation of 6-Trifluoromethyl and 4-Trifluoromethyl-1H-Pyrazolo[3,4-b]Pyridines. J. Fluorine Chem. 2012, 140, 31–37. DOI: https://doi.org/10.1016/j.jfluchem.2012.04.007.
- Baghernejad, B. Application of p-Toluenesulfonic Acid (PTSA) in Organic Synthesis. COC. 2011, 15, 3091–3097. DOI: https://doi.org/10.2174/138527211798357074.
- Lynch, B. M.; Khan, M. A.; Teo, H. C.; Pedrotti, F. Pyrazolo[3,4-b]Pyridines: Syntheses, Reactions, and Nuclear Magnetic Resonance Spectra. Can. J. Chem. 1988, 66, 420–428. DOI: https://doi.org/10.1139/v88-074.
- Kumar, S.; Aggarwal, R.; Kumar, V.; Sadana, R.; Patel, B.; Kaushik, P.; Kaushik, D. Solvent-Free Synthesis of Bacillamide Analogues as Novel Cytotoxic and anti-Inflammatory Agents. Eur. J. Med. Chem. 2016, 123, 718–726. DOI: https://doi.org/10.1016/j.ejmech.2016.07.033.
- The OSIRIS Property Explorer lets you draw chemical structures and calculates on-the-fly various drug-relevant properties whenever a structure is valid. http://www.organic-chemistry.org/prog/peo
- Clark, D. E.; Pickett, S. D. Computational Methods for the Prediction of ‘drug-likeness’. Drug Discov. Today. 2000, 5, 49–58. DOI: https://doi.org/10.1016/s1359-6446(99)01451-8.
- Shaikh, F.; Tai, H. K.; Desai, N.; Siu, S. LigTMap: Ligand and Structure-Based Target Identification and Activity Prediction for Small Molecular Compounds, ChemRxiv. Theoretical and Computational Chemistry, 2021, Version 2, Preprint, DOI: https://doi.org/10.26434/chemrxiv.12923474.v2.
- Singh, S. P.; Kapoor, J. K.; Kumar, D.; Threadgill, M. D. Reaction of Hydrazinoquinolines with Trifluoromethyl-β-Diketones: Structural and Mechanistic Studies. J. Fluorine Chem. 1997, 83, 73–79. DOI: https://doi.org/10.1016/S0022-1139(96)03570-1.
- Uddin, M. J.; Rao, P. N. P.; Knaus, E. E. Design and Synthesis of Novel Celecoxib Analogues as Selective Cyclooxygenase-2 (COX-2) Inhibitors: Replacement of the Sulfonamide Pharmacophore by a Sulfonylazide Bioisostere. Bioorg. Med. Chem. 2003, 11, 5273–5280. DOI: https://doi.org/10.1016/j.bmc.2003.07.005.
- Katz, L. Antituberculous Compounds. II. 2-Benzalhydrazinobenzothiazoles. J. Am. Chem. Soc. 1951, 73, 4007–4010. DOI: https://doi.org/10.1021/ja01152a132.